[Screening, prediction and prevention of type 1 diabetes. Role of the Belgian Diabetes Registry].
Since 1989, all incident cases of type 1 diabetes mellitus and their first-degree relatives younger than 40 years are entered in the Belgian Diabetes Registry (BDR). The incidence of type 1 diabetes is 11.8/100,000 in subjects younger than 15 years and 8.9/100,000 in subjects aged 15 to 40 years. Before 15 years of age, the cases are evenly divided between males and females, whereas in the older group the male-to-female ratio is 1.7. The median duration of symptoms at diagnosis is 3 weeks in patients younger than 15 years versus 8 weeks in those aged 15 to 40 years. The data of the BDR suggest that type 1 diabetes may be more "aggressive" in children than in adults. Autoantibodies are detectable before and during the clinical onset of type 1 diabetes. Over 90% of patients with type 1 diabetes have at least one type of autoantibody directed to beta-cell antigens. However, the nature of biological markers present at clinical onset tends to vary with age. Detection of autoantibodies in first-degree relatives of patients allows to diagnose the disease at a preclinical stage and to evaluate relatively safe preventive interventions in high-risk subjects. Several international studies in this area have been started.